Clinical trial NCT03682276 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-12-01 → 2026-03-12 3. primary completion date: 2023-09-01 → 2026-03-12 4. enrollment: 32 → 33 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06953934 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07298330: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT06111586 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 192 → 197 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06535412 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2026-06-10 → 2028-12-17 3. primary completion date: 2025-12-10 → 2028-12-17
Clinical trial NCT07335510 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-01-01 → 2026-03-30
Clinical trial NCT07538843: start date: 2026-06-01 → 2026-07-30.
Clinical trial NCT02724163: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT07600749 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-15 → 2026-06-18
Clinical trial NCT06666504 updates: 1. status: NOT_YET_RECRUITING → COMPLETED 2. start date: 2024-12-01 → 2024-12-11 3. completion date: 2026-06-30 → 2026-06-20 4. primary completion date: 2025-12-30 → 2026-06-20 5. enrollment type: ESTIMATED → ACTUAL 6. collaborators added: AstraZeneca